April 16, 2013
Fred-a-care plan backfiring with drug costs going up: Forsyth
EDMONTON, AB (April 16, 2013): Health Minister Fred Horne’s contentious new generic drug regime continues to result in high generic drug prices for Albertans, Wildrose Health Critic Heather Forsyth said today. In Question Period today, Forsyth said generic drug company Teva has joined Apotex in refusing Horne’s directive to sell drugs at 18% of brand name prices.
Instead, like Apotex, it has raised the prices on many of its drugs. This will result in several of their drugs being delisted from Alberta Health coverage and Albertans having to pay more out of pocket for them, Forsyth said. On top of that, they will have to apply to Blue Cross for reimbursement, she said. “Minister Horne promised lower prices but instead many Albertans will see their out-of-pocket drug costs skyrocket,” Forsyth said. “He can no longer claim his Fred-a-care plan will cost Albertans less when it actually costs those Albertans who can least afford it more.”